Patents by Inventor Uwe Reinecker

Uwe Reinecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-sulfamoyl-N?-benzopyranpiperidine compounds and uses thereof
    Patent number: 7547708
    Abstract: N-sulfamoyl-N?-benzopyranpiperidine compounds of formula I and their physiologically acceptable acid addition salts, pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment and/or inhibition of glaucoma, epilepsy, bipolar disorders, migraine, neuropathic pain, obesity, type II diabetes, metabolic syndrome, alcohol dependence, and/or cancer, and related concomitant and/or secondary diseases or conditions
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: June 16, 2009
    Assignee: Solvay Pharmaceuticals, Inc.
    Inventors: Jochen Antel, Harald Waldeck, Uwe Schoen, Peter-Colin Gregory, Michael Wurl, Michael Firnges, Dania Reiche, Uwe Reinecker, Holger Sann
  • Sulfamate Compounds and Uses Thereof
    Publication number: 20090104126
    Abstract: A sulfamate compound corresponding to Formula I wherein R1 to R3 and n have defined meanings, pharmaceutical compositions comprising these compounds; a process for preparing these compounds, and the use of such compounds or compositions to treat or inhibit various disorders or disease states in patients in need thereof by administering to such a patient a therapeutically effective amount of such a compound.
    Type: Application
    Filed: October 17, 2008
    Publication date: April 23, 2009
    Applicant: Solvay Pharmaceuticals GmbH
    Inventors: Uwe SCHOEN, Harald Waldeck, Uwe Reinecker, Peter-Colin Gregory, Dania Reiche, Holger Sann, Michael Wurl, Jochen Antel
  • N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
    Publication number: 20070117823
    Abstract: N-sulfamoyl-N?-benzopyranpiperidine compounds of formula I and their physiologically acceptable acid addition salts, pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment and/or inhibition of glaucoma, epilepsy, bipolar disorders, migraine, neuropathic pain, obesity, type II diabetes, metabolic syndrome, alcohol dependence, and/or cancer, and related concomitant and/or secondary diseases or conditions.
    Type: Application
    Filed: November 14, 2006
    Publication date: May 24, 2007
    Applicant: Solvay Pharmaceuticalss GmbH
    Inventors: Jochen Antel, Harald Waldeck, Uwe Schoen, Peter-Colin Gregory, Michael Wurl, Michael Firnges, Dania Reiche, Uwe Reinecker
  • Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
    Publication number: 20050261292
    Abstract: The present invention relates to the use of known and novel N-sulfamoyl-N?-arylpiperazines corresponding to Formula I and their physiologically compatible acid addition salts for the treatment or inhibition of obesity and related conditions.
    Type: Application
    Filed: May 17, 2005
    Publication date: November 24, 2005
    Applicant: Solvay Pharmaceuticals GmbH
    Inventors: Jochen Antel, Michael Firnges, Peter-Colin Gregory, Uwe Reinecker, Uwe Schoen, Harald Waldeck, Michael Wurl, Dania Reiche